Change in proteoglycan metabolism is a characteristic of human patellar tendinopathy

Citations Over TimeTop 10% of 2010 papers

Abstract

Our findings suggest that a change in the proteoglycan content of the extracellular matrix in abnormal tendons results from the altered metabolism of the cells, reflected in the enhanced synthesis of the large proteoglycans aggrecan and versican, and does not appear to result from changes at the level of gene expression.

Related Papers

• → The Regulated Synthesis of Versican, Decorin, and Biglycan: Extracellular Matrix Proteoglycans That Influence Cellular Phenotype(2004)183 cited
• → Up-regulation of extracellular matrix proteoglycans and collagen type I in human crescentic glomerulonephritis(2001)44 cited
• Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis.(1996)
• → Pre-eclampsia-associated alterations in decorin, biglycan and versican of the umbilical cord vein wall(2006)17 cited
• → Reduced decorin affinity for osteogenesis imperfecta collagens(2006)